Vemlidy and Besivo enters Severance Hospital at the same time
‘Vemlidy,’ a Gilead Sciences/Yuhan Corporation’s chronic hepatitis B treatment whose health insurance benefits have been applied from 1 November, and Ildong Pharmaceutical’s ‘Besivo’ entered in Severance Hospital.
Severance Hospital approved Vemlidy and Besivo for a prescription code at its rece...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.